2017 Papillomavirus Diagnostics Market: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment--US, Europe, Japan--Hospitals, Commercial and Public Health Labs, POC Locations

March 2017 | | ID: PFA95BB9BB4EN
Venture Planning Group

Abstracts

This report presents test volumes and sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Papillomavirus tests performed in the following market segments:

• Hospitals
• Commercial/Private Labs
• Physician Offices
• Public Health Labs

Contents

I. INTRODUCTION

II. HPV/PAPILLOMAVIRUS WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests: Pap Smear and HPV
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies

III. FRANCE: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

V. ITALY: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

VIII. UK: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

IX. USA: TEST VOLUME AND DIAGNOSTICS SALES FORECASTS BY MARKET SEGMENT

X. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation @XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XII. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solva
Kreatech
Life Technologies
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

List Of Tables

LIST OF TABLES

France: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
UK: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
USA: Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecasts by Market Segment